The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X Genomics Inc | CL A Common | 88025U109 | 8,351 | 58,977 | SH | SOLE | 58,977 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 10,657 | 1,647,214 | SH | SOLE | 1,647,214 | 0 | 0 | ||
Akero Therapeutics Inc | Common | 00973Y108 | 16,342 | 633,426 | SH | SOLE | 633,426 | 0 | 0 | ||
Aligos Therapeutics Inc | Common | 01626L105 | 98,075 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
ALX Oncology Holdings Inc | Common | 00166B105 | 363,768 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 81,274 | 13,161,847 | SH | SOLE | 13,161,847 | 0 | 0 | ||
Arcutis Biotherapeutics Inc | Common | 03969K108 | 24,393 | 867,170 | SH | SOLE | 867,170 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 15,737 | 205,091 | SH | SOLE | 205,091 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 299,828 | 1,797,745 | SH | SOLE | 1,797,745 | 0 | 0 | ||
Atricure Inc | Common | 04963C209 | 3,595 | 64,573 | SH | SOLE | 64,573 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 6,925 | 500,732 | SH | SOLE | 500,732 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 23,554 | 3,526,093 | SH | SOLE | 3,526,093 | 0 | 0 | ||
Calliditas Therapeutics ADR | SPONSORED ADS | 13124Q106 | 10,457 | 311,030 | SH | SOLE | 311,030 | 0 | 0 | ||
Celldex Therapeutics Inc | Common | 15117B202 | 22,634 | 1,291,875 | SH | SOLE | 1,291,875 | 0 | 0 | ||
Chinook Therapeutics Inc | Common | 16961L106 | 19,131 | 1,206,266 | SH | SOLE | 1,206,266 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 8,473 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
Constellation Pharmaceutical | Common | 210373106 | 4,041 | 140,298 | SH | SOLE | 140,298 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 32,959 | 2,335,889 | SH | SOLE | 2,335,889 | 0 | 0 | ||
Curis Inc | Common | 231269200 | 11,466 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
Cymabay Therapeutics Inc | Common | 23257D103 | 3,360 | 585,394 | SH | SOLE | 585,394 | 0 | 0 | ||
Cytokinetics Inc | Common | 23282W605 | 14,546 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Dyne Therapeutics Inc | Common | 26818M108 | 6,615 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 22,015 | 1,791,257 | SH | SOLE | 1,791,257 | 0 | 0 | ||
Essa Pharma Inc | Common | 29668H708 | 22,594 | 1,893,907 | SH | SOLE | 1,893,907 | 0 | 0 | ||
Genetron Holdings Ltd | ADS | 37186H100 | 88,758 | 6,339,860 | SH | SOLE | 6,339,860 | 0 | 0 | ||
Harmony Biosciences Holdings Inc | Common | 413197104 | 163,916 | 4,534,341 | SH | SOLE | 4,534,341 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 9,632 | 853,143 | SH | SOLE | 853,143 | 0 | 0 | ||
IGM Biosciences Inc | Common | 449585108 | 1,766 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Immunovant Inc | Common | 45258J102 | 16,059 | 347,662 | SH | SOLE | 347,662 | 0 | 0 | ||
Iveric Bio Inc | Common | 46583P102 | 41,229 | 5,966,527 | SH | SOLE | 5,966,527 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 24,142 | 5,817,459 | SH | SOLE | 5,817,459 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | Common | 483119103 | 5,335 | 786,883 | SH | SOLE | 786,883 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 30,731 | 1,618,296 | SH | SOLE | 1,618,296 | 0 | 0 | ||
Kura Oncology Inc | Common | 50127T109 | 17,155 | 525,262 | SH | SOLE | 525,262 | 0 | 0 | ||
Larimar Therapeutics Inc | Common | 517125100 | 17,121 | 799,662 | SH | SOLE | 799,662 | 0 | 0 | ||
Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 77,581 | 2,755,007 | SH | SOLE | 2,755,007 | 0 | 0 | ||
Matinas Biopharma Hldgs Inc | Common | 576810105 | 8,774 | 6,451,612 | SH | SOLE | 6,451,612 | 0 | 0 | ||
Mereo Biopharma Group PLC | ADS | 589492107 | 15,111 | 4,220,938 | SH | SOLE | 4,220,938 | 0 | 0 | ||
Metacrine Inc | Common | 59101E103 | 1,151 | 146,426 | SH | SOLE | 146,426 | 0 | 0 | ||
New Frontier Health Corp | Ord Shs | G6461G106 | 122,980 | 14,300,000 | SH | SOLE | 14,300,000 | 0 | 0 | ||
Nkarta Inc | Common | 65487U108 | 31,486 | 512,225 | SH | SOLE | 512,225 | 0 | 0 | ||
Novavax Inc | Common | 670002401 | 17,561 | 157,487 | SH | SOLE | 157,487 | 0 | 0 | ||
Olema Pharmaceuticals Inc | Common | 68062P106 | 59,551 | 1,238,575 | SH | SOLE | 1,238,575 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 5,727 | 1,325,736 | SH | SOLE | 1,325,736 | 0 | 0 | ||
Ovid Therapeutics Inc | Common | 690469101 | 2,888 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
Passage Bio Inc | Common | 702712100 | 38,024 | 1,487,038 | SH | SOLE | 1,487,038 | 0 | 0 | ||
Poseida Therapeutics Inc | Common | 73730P108 | 10,163 | 926,447 | SH | SOLE | 926,447 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 1,170 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
Revolution Medicines Inc | Common | 76155X100 | 661 | 16,690 | SH | SOLE | 16,690 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | Common | 77313F106 | 17,032 | 310,584 | SH | SOLE | 310,584 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U404 | 30,731 | 1,917,074 | SH | SOLE | 1,917,074 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 134,117 | 3,245,035 | SH | SOLE | 3,245,035 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 1,232 | 174,763 | SH | SOLE | 174,763 | 0 | 0 | ||
Verona Pharma PLC ADR | ADS | 925050106 | 21,340 | 3,048,507 | SH | SOLE | 3,048,507 | 0 | 0 | ||
VYNE Therapeutics Inc | Common | 92941V100 | 1,484 | 939,513 | SH | SOLE | 939,513 | 0 | 0 | ||
Zai Lab Ltd ADR | ADR | 98887Q104 | 23,685 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 20,120 | 1,006,494 | SH | SOLE | 1,006,494 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 13,519 | 286,064 | SH | SOLE | 286,064 | 0 | 0 |